Literature DB >> 17512779

Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness.

A Barceló1, M de la Peña, F Barbé, J Pierola, M Bosch, A G N Agustí.   

Abstract

BACKGROUND: Excessive daytime sleepiness (EDS) occurs often in patients with obstructive sleep apnea syndrome (OSAS). However, not all patients present EDS. We hypothesized that the prostaglandin D2 system (PGD2) may be involved in the pathogenesis of EDS associated with OSAS.
METHODS: We measured the levels of lipocalin-type PGD synthase (L-PGDS), the enzyme that produces PGD2, in the serum of 47 patients with OSAS (26 with and 21 without EDS) and 18 healthy controls.
RESULTS: Patients with EDS had higher levels of L-PGDS (0.73+/-0.06 mg/L) than patients without EDS (0.58+/-0.03 mg/L, p<0.05) and controls (0.62+/-0.02 mg/L, p<0.05). L-PGDS levels in patients without EDS and controls were similar.
CONCLUSION: The increased levels of circulating L-PGDS detected in OSAS patients with EDS suggest a possible role of the prostaglandin D system in the pathophysiology of daytime sleepiness in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512779     DOI: 10.1016/j.sleep.2006.10.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  10 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

4.  Resolution of hypersomnia following identification and treatment of vitamin d deficiency.

Authors:  David E McCarty
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

5.  A meta-analysis: Does vitamin D play a promising role in sleep disorders?

Authors:  Shoumeng Yan; Zhenwei Tian; Hantong Zhao; Changcong Wang; Yingan Pan; Nan Yao; Yinpei Guo; Han Wang; Bo Li; Weiwei Cui
Journal:  Food Sci Nutr       Date:  2020-09-09       Impact factor: 2.863

6.  Clinical Features and Contributing Factors of Excessive Daytime Sleepiness in Chinese Obstructive Sleep Apnea Patients: The Role of Comorbid Symptoms and Polysomnographic Variables.

Authors:  Chuan Shao; Huan Qi; Ruyi Lang; Biyun Yu; Yaodong Tang; Lina Zhang; Xun Wang; Ling Wang
Journal:  Can Respir J       Date:  2019-07-10       Impact factor: 2.409

7.  Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease.

Authors:  Stephanie M Patton; Yong Won Cho; Thomas W Clardy; Richard P Allen; Christopher J Earley; James R Connor
Journal:  Fluids Barriers CNS       Date:  2013-06-07

8.  Obstructive Sleep Apnea With or Without Excessive Daytime Sleepiness: Clinical and Experimental Data-Driven Phenotyping.

Authors:  Sergio Garbarino; Egeria Scoditti; Paola Lanteri; Luana Conte; Nicola Magnavita; Domenico M Toraldo
Journal:  Front Neurol       Date:  2018-06-27       Impact factor: 4.003

9.  The Association between Vitamin D Deficiency and Sleep Disorders: A Systematic Review and Meta-Analysis.

Authors:  Qi Gao; Tingyan Kou; Bin Zhuang; Yangyang Ren; Xue Dong; Qiuzhen Wang
Journal:  Nutrients       Date:  2018-10-01       Impact factor: 5.717

10.  The Association of Sleep Quality and Vitamin D Levels in Hemodialysis Patients.

Authors:  Seyyedeh Mina Hejazian; Elham Ahmadian; Sepideh Zununi Vahed; Leili Faraji Gogani; Farahnoosh Farnood
Journal:  Biomed Res Int       Date:  2021-09-21       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.